Drug Profile
CG 201
Alternative Names: CG-201; CG201 - CG TherapeuticsLatest Information Update: 22 Jun 2015
Price :
$50
*
At a glance
- Originator CG Therapeutics
- Class Antibodies; Cancer vaccines; Contraceptives; Gonadotropin vaccines; Placental hormone vaccines; Pregnancy protein vaccines; Vaccines
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 22 Jun 2015 Discontinued - Phase-II for Solid tumours in USA (Parenteral)
- 04 Apr 2005 Phase-II clinical trials in Solid tumours in USA (Parenteral)